Inhibition of CHK1 kinase for cancer therapy

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The use of chemotherapy for the treatment of cancer has improved outcomes in many types of cancer. Recent reserach has uncovered how and why cancer cells respond to chemotherapy. This reserach proposal will use this knowledge to evaluate a new approach to cancer treatment by targeting a process called cell cycle checkpoints. Specifically this proposal will evaluate the difference between normal cells and cancer cells and use imaging to examine response to these new treatments.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2010

Funding Scheme: NHMRC Project Grants

Funding Amount: $400,527.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Oncology And Carcinogenesis

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

CHK1 | Cancer | Cell Cycle Checkpoints | Positron emissiom tomography | anti cancer drug | assessment of new treatments-drugs for cancer | cancer chemotherapy | p53